Association of bone scan index (BSI) with prognostic biomarkers and survival in men with metastatic castration-resistant prostate cancer (mCRPC) enrolled in a prospective randomized controlled trial of tasquinimod.
Andrew J. Armstrong
Consultant or Advisory Role - Amgen; Bayer; Dendreon; Ipsen; Sanofi
Honoraria - Dendreon; Janssen-Ortho; Pfizer; Sanofi
Research Funding - Active Biotech; Dendreon; Ipsen; Janssen-Ortho; Medivation; Sanofi
Reza Kaboteh
No relevant relationships to disclose
Michael Anthony Carducci
Consultant or Advisory Role - Active Biotech
Jan-Erik Damber
No relevant relationships to disclose
Walter Michael Stadler
No relevant relationships to disclose
Hansen Mats
Employment or Leadership Position - Active Biotech
Lars Edenbrandt
Employment or Leadership Position - Exiqon
Stock Ownership - EXINI Diagnostics
Goran Forsberg
Employment or Leadership Position - Active Biotech
Stock Ownership - Active Biotech
Orjan Nordle
Employment or Leadership Position - Active Biotech
Roberto Pili
Consultant or Advisory Role - Ipsen
Research Funding - Active Biotech
Michael J. Morris
No relevant relationships to disclose